Hologic Inc (HOLX)

79.61
+0.41(+0.52%)
After Hours
79.61
0.00(0.00%)
- Real-time Data
  • Volume:
    1,050,018
  • Day's Range:
    79.41 - 80.31
  • 52 wk Range:
    59.78 - 86.65

HOLX Overview

Prev. Close
79.2
Day's Range
79.41-80.31
Revenue
4.47B
Open
79.5
52 wk Range
59.78-86.65
EPS
3.96
Volume
1,050,018
Market Cap
19.63B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,602,930
P/E Ratio
20.16
Beta
1.03
1-Year Change
4.68%
Shares Outstanding
246,554,026
Next Earnings Date
Apr 26, 2023
What is your sentiment on Hologic?
or
Market is currently closed. Voting is open during market hours.

Hologic Inc Company Profile

Hologic Inc Company Profile

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Read More

Analyst Price Target

Average86.04 (+8.08% Upside)
High95.00
Low70.00
Price79.61
No. of Analysts19
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellNeutralBuyStrong BuyStrong Buy
Technical IndicatorsStrong SellSellStrong BuyStrong BuyStrong Buy
SummaryStrong SellNeutralStrong BuyStrong BuyStrong Buy